77 related articles for article (PubMed ID: 2914408)
41. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients.
Shah GM; Ross EA; Sabo A; Pichon M; Reynolds RD; Bhagavan H
Am J Kidney Dis; 1992 Jul; 20(1):42-9. PubMed ID: 1621677
[TBL] [Abstract][Full Text] [Related]
42. Antihistamine effect of supplemental ascorbic acid and neutrophil chemotaxis.
Johnston CS; Martin LJ; Cai X
J Am Coll Nutr; 1992 Apr; 11(2):172-6. PubMed ID: 1578094
[TBL] [Abstract][Full Text] [Related]
43. Ascorbic acid aggravates secondary hyperoxalemia in patients on chronic hemodialysis.
Balcke P; Schmidt P; Zazgornik J; Kopsa H; Haubenstock A
Ann Intern Med; 1984 Sep; 101(3):344-5. PubMed ID: 6465702
[No Abstract] [Full Text] [Related]
44. The oxalate level in ultrafiltrate fluid collected from a dialyzer is useful for estimating the plasma oxalate level in hemodialysis patients.
Ogi M; Abe R; Nishitani T; Wakabayashi M; Wakabayashi T
Clin Exp Nephrol; 2006 Jun; 10(2):118-23. PubMed ID: 16791397
[TBL] [Abstract][Full Text] [Related]
45. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal.
Costello JF; Sadovnic MJ; Cottington EM
J Am Soc Nephrol; 1991 Jun; 1(12):1289-98. PubMed ID: 1912391
[TBL] [Abstract][Full Text] [Related]
46. Effect of vitamin C supplementation on renal oxalate deposits in five-sixths nephrectomized rats.
Ono K; Ono H; Ono T; Kikawa K; Oh Y
Nephron; 1989; 51(4):536-9. PubMed ID: 2739830
[TBL] [Abstract][Full Text] [Related]
47. [Oxalic acid metabolism in chronic renal failure].
Balcke P
Wien Klin Wochenschr Suppl; 1985; 160():1-15. PubMed ID: 3859955
[TBL] [Abstract][Full Text] [Related]
48. Major factors modulating the serum oxalic acid level in hemodialysis patients.
Ogawa Y; Machida N; Jahana M; Gakiya M; Chinen Y; Oda M; Morozumi M; Sugaya K
Front Biosci; 2004 Sep; 9():2901-8. PubMed ID: 15353324
[TBL] [Abstract][Full Text] [Related]
49. Plasma oxalate levels in prevalent hemodialysis patients and potential implications for ascorbic acid supplementation.
Liu Y; Weisberg LS; Langman CB; Logan A; Hunter K; Prasad D; Avila J; Venkatchalam T; Berns JS; Handelman GJ; Sirover WD
Clin Biochem; 2016 Oct; 49(15):1133-1139. PubMed ID: 27265723
[TBL] [Abstract][Full Text] [Related]
50. [Kinetics of oxalate in hemodialysis].
Marangella M; Petrarulo M; Vitale C; Cosseddu D; Linari F
Minerva Urol Nefrol; 1991; 43(3):165-9. PubMed ID: 1817340
[TBL] [Abstract][Full Text] [Related]
51. The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis.
Rolton HA; McConnell KM; Modi KS; Macdougall AI
Nephrol Dial Transplant; 1991; 6(6):440-3. PubMed ID: 1876286
[TBL] [Abstract][Full Text] [Related]
52. [Effect of vitamin C on heparin activity in patients with chronic renal failure treated with hemodiaglysis].
Chmielewska J; Poplawski A
Pol Tyg Lek; 1977 Jul; 32(28):1079-80. PubMed ID: 887495
[No Abstract] [Full Text] [Related]
53. Pathogenesis of acquired renal cysts in hemodialysis patients. The role of oxalate crystal deposition in renal tubules.
Ono K; Yasukohchi A; Kikawa K
ASAIO Trans; 1987; 33(3):245-9. PubMed ID: 3314920
[TBL] [Abstract][Full Text] [Related]
54. [L-ascorbic acid and long-term dialysis program].
Mydlík M; Derzsiová K; Takác M
Cas Lek Cesk; 1976 Jan; 115(4):115-9. PubMed ID: 1253213
[No Abstract] [Full Text] [Related]
55. Ion chromatographic determination of plasma oxalate in healthy subjects, in patients with chronic renal failure and in cases of hyperoxaluric syndromes.
Petrarulo M; Bianco O; Marangella M; Pellegrino S; Linari F; Mentasti E
J Chromatogr; 1990 Jul; 511():223-31. PubMed ID: 2211912
[TBL] [Abstract][Full Text] [Related]
56. [Hyperoxalemia and secondary oxalosis of chronic renal insufficiency].
Schillinger F; Montagnac R; Milcent T
Nephrologie; 1990; 11(4):211-5. PubMed ID: 2074920
[No Abstract] [Full Text] [Related]
57. Ascorbic acid depletion in patients undergoing chronic hemodialysis.
Sullivan JF; Eisenstein AB
Am J Clin Nutr; 1970 Oct; 23(10):1339-46. PubMed ID: 4990916
[No Abstract] [Full Text] [Related]
58. Immunologic competence of hemodialysis patients following withdrawal of vitamin C supplement.
Ganguly R; Ramirez G; Fuller S; Curry A; Chamberlain P
Nephron; 1987; 47(4):299-304. PubMed ID: 3696334
[TBL] [Abstract][Full Text] [Related]
59. [Supply of ascorbic acid requirement in chronic kidney insufficiency and its modification by means of extracorporeal hemodialysis].
Kasper H; Muskat E; Mueller K
Klin Wochenschr; 1970 Aug; 48(15):946-7. PubMed ID: 5519313
[No Abstract] [Full Text] [Related]
60. Plasma and whole blood concentrations of ascorbic acid in patients undergoing long-term hemodialysis.
Bradley DW; Maynard JE; Webster H
Am J Clin Pathol; 1973 Aug; 60(2):145-7. PubMed ID: 4720395
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
